2nd Quarter - Report

BROWN RUDNICK LLP for HOSPIRA, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Issues relating to drug shortages, patent use codes and drug labeling (RIN:0910-AG94: FDA Proposed Rule on Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products)

LobbyistCovered position, as disclosed
CHRISTOPHER BOWLIN Secr for Congr & Intgv Affairs, Dept. Labor 01-02
LISA LAYMAN SPA, Sen Stabenow(05-07)
HENRY W MENN Min SD & Counsel, Cmte on Vet Affairs (04)

Contacted: SENATE; White House Office; HOUSE OF REPRESENTATIVES

Health Issues HCR

Implementation of the Biologics Price Competition and Innovation Act (BPCIA) relating to biosimilar naming. Issues relating to opiate overdosing

LobbyistCovered position, as disclosed
CHRISTOPHER BOWLIN —
LISA LAYMAN —
HENRY W MENN —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.